Users Online:40
Home
About us
Editorial board
Search
Ahead of print
Current issue
Archives
Submit article
Instructions
Subscribe
Contacts
Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2011| October-December | Volume 5 | Issue 4
Online since
December 1, 2014
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
BOOK REVIEW
Homoeopathic materia medica of indian drugs
LK Nanda
October-December 2011, 5(4):34-35
Full text not available
[PDF]
4,734
804
-
EDITORIAL
Editorial
Alok Kumar
October-December 2011, 5(4):0-0
Full text not available
[PDF]
1,035
3,678
-
ORIGINAL ARTICLES
Evaluation of anti-leukemic activity of potentised
Catharanthus roseus
: An in-vitro study
R Usha Kushwaha, U Bhagwat Nagargoje
October-December 2011, 5(4):7-15
Alcoholic extract of potentised
Catharanthus roseus
(L.) G. Don. was evaluated for its anti-leukemic activity in in-vitro model. For this
in- vitro
study two cell lines namely, jurkat and K562 for promyelocytic leukemia and chronic myeloid leukemia were used. The cell lines were grown in Roswell Park Memorial Institute Medium (RPMI 1640 medium) containing 10% fetal bovine serum and 2mM L-glutamine. Doxorubicin (Adriamycin, ADR) was used as positive control drug. Growth inhibition of 50 % (GI50) was calculated from [(test growth in the presence of drug at the four concentration levels Ti - time zero Tz)/( control growth C-Tz)] x 100 = 50], which is the drug concentration resulting in a 50% reduction in the net protein increase in control cells during the drug incubation. The drug concentration resulting in total growth inhibition (TGI) was calculated from Ti = Tz. The LC50 (concentration of drug resulting in a 50% reduction in the measured protein at the end of the drug treatment as compared to that at the beginning) indicating a net loss of cells following treatment is calculated from [(Ti-Tz)/Tz] x 100 = -50 in sulforhodamine B (SRB) assay. The
Catharanthus roseus
in 2X potency showed maximum anti-leukemic activity in molar drug concentration of 20 μg/ml on human leukemic cell line K562 for chronic myeloid leukemia.
[ABSTRACT]
Full text not available
[PDF]
1,672
1,145
-
REPRINT ARTICLE
An exploratory study on scientific investigations in homeopathy using medical analyzer
Nirupama Mishra, K Charan Muraleedharan, Akalpita Sriniwas Paranjpe, Devendra Kumar Munta, Hari Singh, Chaturbhuja Nayak
October-December 2011, 5(4):1-6
Background:
The action of homeopathic medicines, in ultra-high dilution, is not directly observable. An attempt was made to explore autonomic response of selective homeopathic medicines, in healthy persons, using Medical Analyzer System (Electronics Division, Bhabha Atomic Research Centre, Mumbai, India).
Objective:
The objective of the study was to observe the action of homeopathic medicines on physiologic variability of heart rate and blood flow.
Material and methods:
Pre- and postinterventional variability spectra of heart rate and blood flow of 77 subjects were recorded with the Medical Analyzer System, administering homeopathic preparations of
Aconitum napellus
(6c, 10M),
Arsenicum album
(200c, 1M),
Gelsemium sempervirens
(200c, 1M),
Phosphorus
(200c, 1M),
Pulsatilla nigricans
(200c) and
Sulphur
(200c, 1M) versus placebo control. The amplitude of the peaks viz. low-frequency, medium-frequency, and high-frequency was measured for postintervention analysis. An increase in the amplitude of any valid peak by 100% or a decrease by 50% was considered as significant change.
Results:
Aconitum napellus
produced a response in heart rate variability (HRV) with 30c potency and in blood flow variability with 1M potency.
Sulphur
200c and 1M,
Gelsemium
200c and
Pulsatilla
200c, produced a 62.5% response in HRV against the placebo response of 16.6%.
Gelsemium, Phosphorus
, and
Sulphur
produced a response in blood flow variability with a 1M potency, similar to the response of
Aconitum napellus
1M.
Conclusions:
These data suggest that it is possible to record the response of homeopathic medicines on physiologic parameters of the autonomic nervous system.
[ABSTRACT]
Full text not available
[PDF]
1,304
1,104
-
ORIGINAL ARTICLES
Bacopa monnieri
- A multicentric, randomized, double-blind homoeopathic pathogenetic trial
Rajpal , Vinay Kr Singh, VA Siddiqui, C Nayak, PC Mal, DB Sarkar
October-December 2011, 5(4):22-27
Objective:
To elicit the pathogenetic response of the drug Bacopa monnieri in homoeopathic potencies on healthy human beings.
Methodology:
Drug
Bacopa
monnieri was proved by the Central Council for Research in Homoeopathy through randomized, double-blind, placebo-controlled method. The study was conducted at two centers. The drug was proved in three potencies (6C, 30C and 200C) on 32 apparently healthy volunteers who were selected after conducting pre-trial medical examination by the medical specialists and routine laboratory investigations. In the first phase volunteers were given 56 doses (04 doses per day for 14 days) of placebo. In the next three phases 56 doses (04 doses per day for 14 days) of each potency or placebo were consumed. The symptoms generated during the trial period were noted by the volunteers and elaborated by the Proving Masters. The data obtained from both the centers was compiled at provingcum- data processing cell at CCRH headquarters after de-coding.
Observations:
Out of the 20 provers who were on actual drug trial, 07 manifested symptoms. Drug was able to produce symptoms in all three potencies more or less related to every part of the body.
Conclusion:
The pathogenetic responses elicited during the proving trial expands the scope of use of the drug
Bacopa
monnieri and will benefit the research scholars and clinicians. These symptoms will carry more value when verified clinically.
[ABSTRACT]
Full text not available
[PDF]
1,679
307
-
CASE REPORT
A case of multiple urinary calculi treated with homoeopathy
P Paul Sumithran
October-December 2011, 5(4):28-33
A case of multiple urinary calculi, with size varying from five to seven millimeters in the left kidney and four to six millimeters in the right kidney, a thirteen millimeter stone in the left lower part of the ureter and a 20 x 13 millimeter stone in the base of the urinary bladder presenting complaints of burning micturition and pain in the lumbar region reported at the O.P.D of the Central Research Institute for Homoeopathy at Kottayam, Kerala. Patient was having urolithiasis complaints since four years and had undergone both allopathic and ayurvedic treatment, but the response was not satisfactory. After repertorisation, Nitric acid 30C was prescribed. Two doses of this homoeopathic medicine proved to be effective.
[ABSTRACT]
Full text not available
[PDF]
1,605
350
-
ORIGINAL ARTICLES
Pharmacognostic and physico-chemical evaluation of
Lactuca sativa L
.
P Subramanian, P Padma Rao, PR Reddy, HC Gupta
October-December 2011, 5(4):16-21
Lactuca sativa
L. is an erect, annual herb belonging to the family Asteraceae. The leaves are useful in angina pectoris, ascitis, asthma, constipation, cough, diarrhea, hysteria, gonorrhoea, affections of liver and spleen and pain in pylorus and spinal cord. Leaves are long, thin, orbicular or oblong, obovate, crisp and radical. The trichomes are uniseriate filiform capitate, uniseriate macroform conical and biseriate filiform capitate types; mesophyll is undifferentiated; laticiferous ducts and prismatic crystals are present in ground tissue; midvein bundle is bicollateral. The powder microscopic and organoleptic characters are provided. Physico-chemical parameters of raw drug viz., extractive values, ash values, formulation, besides weight per ml., total solids, alcohol content along with thin layer chromatography (TLC) and ultraviolet spectroscopic (UV) studies have been undertaken for mother tincture for the first time.
[ABSTRACT]
Full text not available
[PDF]
1,274
224
-
Feedback
Subscribe
Sitemap
|
What's New
|
Feedback
|
Disclaimer
© Indian Journal of Research in Homoeopathy | Published by Wolters Kluwer -
Medknow
Online since 05 July, 2013